Globus Medical Inc news

   Watch this stock
Showing stories 1 - 10 of about 75   

Articles published

GMED 24.03 +0.07 (0.29%)
price chart
Globus Medical (GMED) Beats on Q4 Earnings, Sales in Line
Musculoskeletal implant manufacturer, Globus Medical Inc. (GMED - Snapshot Report), reported adjusted earnings per share ("EPS") of 30 cents in the fourth quarter of 2014, beating the Zacks Consensus Estimate by 4 cents.
Canaccord Genuity Analysts Give Globus Medical a $31.00 Price Target (GMED)  Mideast Time
Globus Medical Announces Acquisition of Transplant Technologies of Texas
AUDUBON, Pa.--(BUSINESS WIRE)--Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal implant manufacturer, today announced that it has acquired allograft tissue processor Transplant Technologies of Texas, Ltd.
Related articles »  
Leerink Swann Analyst Recommendation Update on Globus Medical, Inc.
Brokerage firm Leerink Swann maintains its rating on Globus Medical, Inc. (NYSE:GMED). As per the latest information, the brokerage house raises the price target to $29 per share from a prior target of $28.
WallachBeth Capital Raises Globus Medical Price Target to $30.00 (GMED)  Dakota Financial News
Leerink Swann Boosts Globus Medical Price Target to $29.00 (GMED)  sleekmoney
Why Globus Medical Inc. Shares Spiked Higher
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
Related articles »  
Globus Medical Reports Preliminary Fourth Quarter and Full Year Sales Results
AUDUBON, Pa.--(BUSINESS WIRE)--Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced preliminary unaudited sales results for the year ending December 31, 2014, in advance of its annual national sales ...
Globus Medical Announces Preliminary Q4 amp; 2014 Sales Results
Globus Medical Analyst Roundup Following Preliminary Q4 Results  Benzinga
Related articles »  
Globus Medical Announces the Acquisition of Branch Medical Group Inc.
Globus Medical Inc. (NYSE: GMED) a leading musculoskeletal implant manufacturer today announced that it has entered into an agreement to acquire Branch Medical Group Inc. (�BMG�) a third party manufacturer of high precision medical devices.
Globus Medical Sees Unusually-High Trading Volume After Strong Earnings ...  Intercooler
Analyst Rating Update on Globus Medical Inc
Globus Medical Inc (NYSE:GMED) has received a hold rating for the short term, according to the latest rank of 3 from research firm, Zacks.
Globus Medical PT Raised to $30.00 at WallachBeth Capital (GMED)
Globus Medical (NASDAQ:GMED) last issued its quarterly earnings data on Wednesday, February 25th. The company reported $0.30 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.25 by $0.05.
Globus Medical Schedules Third Quarter 2014 Earnings Release and ...
AUDUBON, Pa.--(BUSINESS WIRE)--Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, will announce its financial results for the third quarter ended September 30, 2014 after the market close on Thursday, October 30, 2014 ...
Related articles »  
FDA reaches $1 million settlement with Pennsylvania medical device firm
The U.S. Food and Drug Administration has reached a $1 million civil money penalty settlement with Globus Medical Inc., of Audubon, Pa.
Globus Medical and David C. Paul, Agree to Settle FDA Administrative Complaint  Business Wire (press release)
Orthopedic device CEO fined for distributing products without FDA's OK  MedCity News
Related articles »